Cotinga Pharmaceuticals Inc. (COT.V) (COT) News Today → [FREE Ticket] 27 Crypto Experts Reveal Their #1 Picks (From Crypto 101 Media) (Ad) Free COT Stock Alerts C$0.04 -0.03 (-41.67%) (As of 10/14/2020) Add Compare Share Share HeadlinesStock Analysis All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative May 1, 2024 | wsj.comKalVista Pharmaceuticals Inc.February 14, 2024 | wsj.comLexicon Pharmaceuticals Inc.November 5, 2023 | morningstar.comAcumen Pharmaceuticals Inc ABOSJuly 22, 2023 | seekingalpha.comSXTP 60 Degrees Pharmaceuticals, Inc.April 28, 2023 | marketwatch.com8-K: ENANTA PHARMACEUTICALS INCFebruary 18, 2023 | seekingalpha.comIronwood Pharmaceuticals, Inc. 2022 Q4 - Results - Earnings Call PresentationJanuary 24, 2023 | seekingalpha.comPTPI Petros Pharmaceuticals, Inc.October 11, 2022 | wsj.comAmylyx Pharmaceuticals Inc.August 12, 2022 | yahoo.comPepGen Reports Second Quarter 2022 Financial Results and Recent Corporate DevelopmentsMay 26, 2022 | finance.yahoo.comExagen Inc. to Participate in the William Blair 42nd Annual Growth Stock Conference Get Cotinga Pharmaceuticals Inc. (COT.V) News Delivered to You Automatically Sign up to receive the latest news and ratings for COT and its competitors with MarketBeat's FREE daily newsletter. Email Address [FREE Ticket] 27 Crypto Experts Reveal Their #1 Picks (Ad)Did you see bitcoin crossed $70k again? Don't miss the next bull run. Because while Bitcoin and Ethereum steal all the headlines… It’s often the cryptos flying under the radar that turn small stakes into life-changing windfalls. Claim your free seat by clicking here now. COT Media Mentions By Week COT Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. COT News Sentiment▼0.000.77▲Average Medical News Sentiment COT News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. COT Articles This Week▼00▲COT Articles Average Week Get Cotinga Pharmaceuticals Inc. (COT.V) News Delivered to You Automatically Sign up to receive the latest news and ratings for COT and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: SVS News FRX News MDNA News ONC News SVA News TH News PMN News DMT News MBX News IBT News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (CVE:COT) was last updated on 6/2/2024 by MarketBeat.com Staff From Our PartnersTrump’s Gift Could Unleash $51 Billion in New WealthWealthpin ProBiden replacement revealed?Paradigm PressBuy this small stock before coming AI Tidal WaveChaikin AnalyticsWarren Buffett, Jeff Bezos, Michael Bloomberg, & 48 Members of Congress Are Buying ONE Sector…InvestorPlaceExposed: 10 CENT Crypto to Explode May 20th?True Market InsidersHe Is Giving Away BitcoinCrypto Swap ProfitsWrite this ticker symbol down…StocksToTradeShocking $16T Elon Musk Crypto LeakCrypto 101 Media Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cotinga Pharmaceuticals Inc. (COT.V) Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
